MNPR
Monopar Therapeutics
$73.39
+$1.55 (+2.16%)Oct 28, 2026
Key metrics
The numbers that frame MNPR today
- Market cap
- $492.61M
- ROIC
- -28.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $50.07
- 52wk High
- $124.42
Growth
Revenue and earnings trend for MNPR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MNPR
Is Monopar Therapeutics a good buy?
Hold. Monopar Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Monopar Therapeutics is selling at a high price.
What is the market capitalization of MNPR?
Monopar Therapeutics's market capitalization is $492.61M.
What is the 52-week high for MNPR stock?
The 52-week high for Monopar Therapeutics is $124.42. The current close of $73.39 is 41% below that high.
What is the 52-week low for MNPR stock?
The 52-week low for Monopar Therapeutics is $50.07. The current close of $73.39 is 46.6% above that low.
Does MNPR stock pay dividends?
Monopar Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MNPR?
Monopar Therapeutics's Debt / Equity ratio is 0.